| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 09/14/2006 | WO2006056433A3 Novel 2-cyano-3-(halo)alkoxy-benzenesulfonamide compounds for combating animal pests |
| 09/14/2006 | WO2004073634A3 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/14/2006 | US20060205980 analgesic activity for treating pain, migraine, neuralgia, fibromyalgia; nontoxic, good absorption, good half-life, good solubility, low protein binding affinity, side effect reduction; 2-(4-tert-butyl-3,5-difluorophenoxy)-N-(1-{3-methyl-4-[(methylsulfonyl) amino]phenyl}ethyl)acetamide |
| 09/14/2006 | US20060205812 5-Amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 09/13/2006 | EP1700109A2 Acousto-mechanical detection systems and methods of use |
| 09/13/2006 | EP1699756A2 Synthesis of ionic liquids |
| 09/13/2006 | EP1699755A2 Process for preparing fluorochemical monoisocyanates |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1833003A Sulfonamide anions as catalysts for nco oligomerization |
| 09/13/2006 | CN1832920A Aryl and heteroaryl compounds, compositions, and methods of use |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/13/2006 | CN1274661C Fluorine compounds and water and oil-repellant compositions |
| 09/12/2006 | US7105698 Process for the separation of R(-)-and S(+)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2- methoxybenzenesulfonamide |
| 09/12/2006 | US7105572 Cardiovascular disorders |
| 09/12/2006 | US7105564 7-(3-{[5-(Pyrrole-1-sulfonyl)-thiophene-2-carbonyl]-amino}-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid; thromboxane A2 receptor and a prostaglandin D2 receptor; for all of eosinophilic infiltration, advance of respiratory anaphylaxis and respiratory contraction |
| 09/12/2006 | CA2241788C Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them |
| 09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 09/08/2006 | WO2006093823A1 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 09/08/2006 | CA2599808A1 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 09/07/2006 | US20060199864 Selection of pH-dependent compounds for in vivo therapy |
| 09/07/2006 | US20060199838 3-hydroxy-N-(3-hydroxy-4-methoxyphenyl)-4-methoxybenzamide, used in the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyloidosis, such as observed non-insulin depepndent diabetes |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/07/2006 | US20060199822 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 09/06/2006 | EP1697316A1 Novel intermediates for the synthesis of (r)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation |
| 09/06/2006 | EP1697309A2 Benzoyl-substituted phenylalanine amides |
| 09/06/2006 | EP1697304A1 Peroxisome proliferator activated receptor modulators |
| 09/06/2006 | EP1697301A2 Aminoalcohol derivatives |
| 09/06/2006 | EP1696915A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 09/05/2006 | US7101915 P-terphenyl compounds |
| 08/31/2006 | WO2006091870A2 Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis |
| 08/31/2006 | WO2005080313A9 Sulfonamide derivatives for the treatment of diseases |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | CA2599169A1 Synthesis of (e)-alpha, beta unsaturated sulfides, sulfones, sulfoxides and sulfonamides |
| 08/30/2006 | EP1695958A1 Method for producing chlorosulfonyl isocyanate |
| 08/30/2006 | EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694281A2 Biphenyl compounds and methods |
| 08/30/2006 | EP1255724B1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 08/30/2006 | CN1826310A Novel aminobenzophenone compounds |
| 08/30/2006 | CN1824650A Method of preparing sulfone amide and method of using said sulfone smine to prepare N-substituted imine |
| 08/30/2006 | CN1272316C Benzamides and related inhibitors of factor Xa |
| 08/29/2006 | US7098226 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/24/2006 | WO2006086923A1 4-hydroxy pentanamides, the preparation and use thereof |
| 08/24/2006 | WO2005004810A3 Arylsulfonamide derivatives |
| 08/24/2006 | US20060189810 Novel sulfonamide inhibitors of aspartyl protease |
| 08/24/2006 | US20060189578 Method for the synthesis of compounds of formula I and their uses thereof |
| 08/24/2006 | US20060188788 Solvents and novel electrolytic compositions having a large range of stability and high conductivity |
| 08/23/2006 | EP1692100A1 Method of preparing optically pure phenethylamine derivatives |
| 08/23/2006 | EP1691804A1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
| 08/23/2006 | EP1324981B1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 08/23/2006 | EP1027328B1 Substituted anilides |
| 08/23/2006 | EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
| 08/23/2006 | CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 08/22/2006 | US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/22/2006 | US7094903 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 08/17/2006 | WO2006084688A1 HIV protease inhibitors |
| 08/17/2006 | WO2005107762A3 Certain chemical entities, compositions, and methods |
| 08/17/2006 | US20060183944 Process for preparing reverse transcriptase inhibitors |
| 08/17/2006 | US20060183933 Method of hydroaminating N-alkenoylcarbamates with primary aromatic amines |
| 08/17/2006 | CA2594395A1 Hiv protease inhibitors |
| 08/16/2006 | EP1690853A1 W-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/16/2006 | EP1689716A1 Biaryl sulfonamides and methods for using same |
| 08/16/2006 | EP1689713A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease |
| 08/16/2006 | EP1689707A1 Novel compounds for the treatment of obesity |
| 08/16/2006 | EP1689380A2 Method for treating adamts-5-associated disease |
| 08/16/2006 | EP1301467B1 9-substituted minocycline compounds |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/15/2006 | US7091247 urotensin antagonists; vasoactive agents |
| 08/15/2006 | US7091219 Administering an effective amount of bis-sulfonamide hydroxyethyl-amino derivative to a HIV patient to prevent the viral replication |
| 08/15/2006 | CA2256309C Amidino protease inhibitors |
| 08/10/2006 | WO2006083924A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors |
| 08/10/2006 | WO2006081997A2 Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostate hyperplasia, prostate carcinoma, and spinobulbar muscular atrophy |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060177717 membrane electrodes; electrocatalysts; fuel cells |
| 08/10/2006 | DE102005005399A1 Use of 2,4-dihydroxy-3-methylbenzoate derivatives for preparing medicaments or as basic substance for the development of other agents used for treating benign prostate hyperplasia, prostate carcinoma or spinobulbar muscular atrophy |
| 08/10/2006 | DE102005005397A1 Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms Isolation of N-butyl benzene, synthesis of benzenesulfonamide derivatives as well as using N-butyl benzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostatic hyperplasia and / or prostate carcinoma |
| 08/10/2006 | CA2596634A1 Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostatic hyperplasia, prostate carcinoma and spinobulbar muscular atrophy |
| 08/10/2006 | CA2596444A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors |
| 08/09/2006 | EP1687265A2 Vitamin d receptor modulators |
| 08/09/2006 | EP1546673A4 Novel green and orange fluorescent labels and their uses |
| 08/09/2006 | EP1454316B1 Lubricant for magnetic recording medium and use thereof |
| 08/09/2006 | EP1401806B1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 08/09/2006 | CN1816522A Advanced route for the synthesis of CPLA2 inhibitors |
| 08/09/2006 | CN1268610C Sulfonamide derivatives |
| 08/08/2006 | CA2238619C Preparation of bis(fluoroalkylenesulfonyl)imides and (fluoroalkylsulfonyl) (fluorosulfonyl)imides |
| 08/08/2006 | CA2200707C Novel prostaglandin synthase inhibitors |
| 08/08/2006 | CA2188835C Novel compounds and methods for synthesis and therapy |
| 08/03/2006 | WO2005060456A8 Method for treating adamts-5-associate disease |
| 08/03/2006 | US20060173214 Process for the preparation of enantiomerically pure (r) or (s)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide |
| 08/03/2006 | US20060173204 New 3-aryl propionic acid derivatives and analogs |
| 08/03/2006 | US20060172936 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 08/02/2006 | EP1686113A1 Inhibitors of aspartyl protease |
| 08/02/2006 | EP1685119A1 N-acylsulfonamide apoptosis promoters |
| 08/02/2006 | EP1685094A1 Acylurea connected and sulfonylurea connected hydroxamates |
| 08/02/2006 | EP1685093A1 N-substituted p-menthane carbosamided |
| 08/02/2006 | EP1133476B1 Iminoguanidine derivatives, preparation method, use as medicines |
| 08/02/2006 | EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/02/2006 | EP1001785B1 Use of colchinol derivatives as vascular damaging agents |